Orchestra BioMed Holdings, Inc. (OBIO) Revenue by Year
Orchestra BioMed Holdings, Inc. generated $33.5M in revenue in fiscal year 2025. This represents an increase of 1169.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $32.0M in revenue. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Orchestra BioMed Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
OBIO Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
OBIO Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Orchestra BioMed Holdings, Inc. financials
Frequently Asked Questions
What was Orchestra BioMed Holdings, Inc.'s revenue in fiscal year 2025?
Orchestra BioMed Holdings, Inc. generated $33.5M in revenue in fiscal year 2025.
How fast is Orchestra BioMed Holdings, Inc.'s revenue growing?
Orchestra BioMed Holdings, Inc. (OBIO) revenue rose by 1169.2% year over year, from $2.6M to $33.5M in fiscal year 2025.
What is Orchestra BioMed Holdings, Inc.'s revenue over the last twelve months?
Orchestra BioMed Holdings, Inc. (OBIO) reported $32.0M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was Orchestra BioMed Holdings, Inc.'s revenue in the most recent quarter?
Orchestra BioMed Holdings, Inc. (OBIO) reported $88K in revenue in Q2 2026. This represents a decrease of 89.5% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Orchestra BioMed Holdings, Inc. (OBIO) reported on that line in every period on record.